DSpace Repository

Cerebral Manifestations of Amyloidosis: questions of early diagnosis and therapy

Show simple item record

dc.contributor.author Rahimbayeva, Gulnora
dc.date.accessioned 2024-01-16T13:17:53Z
dc.date.available 2024-01-16T13:17:53Z
dc.date.issued 2023-08
dc.identifier.uri http://repository.tma.uz/xmlui/handle/1/10353
dc.description.abstract . Cerebral amyloid angiopathy (CAA) is the generally accepted term used to define amyloid deposits in the walls of leptomeningeal and cortical arteries of medium and small diameter, arterioles, less often capillaries and veins. Cerebral amyloid angiopathy is an important cause of cerebral haemorrhage, although it can also lead to ischemic infarction and dementia. Patients with CAA may have a wide clinical spectrum, including cognitive decline, lobar intracranial haem orrhage, and transient focal neurological episodes (recurrent, stereotyped, transient episodes of smoothly spreading pares thesia’s, numbness, or weakness, usually lasting seconds to minutes, usually resolving within a similar pe en_US
dc.language.iso en en_US
dc.publisher Journal of education and scientific medicine en_US
dc.subject Cerebral amyloid angiopathy, Alzheimer's disease, intracranial haemorrhage, MRI en_US
dc.title Cerebral Manifestations of Amyloidosis: questions of early diagnosis and therapy en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account